Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Viking Thera
(NQ:
VKTX
)
51.24
+0.98 (+1.95%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Viking Thera
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
19
20
Next >
What Is the Best Weight Loss Stock to Buy Now? Our Top 3 Picks
May 02, 2024
Data indicates that many more Americans have become aware of the dangers of obesity. Here are the best weight loss stocks to buy now.
Via
InvestorPlace
Here's How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years
May 01, 2024
Via
Benzinga
Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge
May 01, 2024
A slip in the market could give investors a rare opportunity to get some top biotech stocks to buy at a considerable discount.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
April 30, 2024
Via
Benzinga
Check Out What Whales Are Doing With VKTX
April 30, 2024
Via
Benzinga
Is Viking Therapeutics Incredibly Undervalued?
April 28, 2024
The biotech's weight loss drug candidate could fuel a premium-laden buyout, but risks abound.
Via
The Motley Fool
Can This High-Flying Stock 10x in 10 Years?
April 28, 2024
This midcap biotech could see huge success ahead -- or disappointment.
Via
The Motley Fool
Viking Therapeutics Unusual Options Activity
April 26, 2024
Via
Benzinga
Looking At Viking Therapeutics's Recent Unusual Options Activity
April 22, 2024
Via
Benzinga
1 Little-Known Vanguard Index Fund to Buy Before It Soars 50%, According to a Wall Street Analyst
April 28, 2024
Tom Lee of Fundstrat Global Advisors thinks the small-cap Russell 2000 could climb 50% by the end of 2024.
Via
The Motley Fool
3 Biotech Stocks to Buy on the Dip: April 2024
April 26, 2024
With medical innovation being a resilient space, investors can have confidence with these biotech stocks to buy on the dip.
Via
InvestorPlace
3 Millionaire-Maker Biotech Stocks
April 25, 2024
The risk at these companies is above average, and they're sure to remain volatile. This volatility, however, includes explosively bullish potential.
Via
The Motley Fool
VKTX Stock Earnings: Viking Therapeutics Beats EPS for Q1 2024
April 24, 2024
VKTX stock results show that Viking Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Viking Therapeutics Reports Q1 Results: 'An Exceptional Period' Says CEO
April 24, 2024
Viking Therapeutics reports quarterly losses of 26 cents per share which beat the analyst consensus estimate of losses of 28 cents by 7.14%. Research and development expenses were $24.1 million for the...
Via
Benzinga
Market Whales and Their Recent Bets on VKTX Options
April 18, 2024
Via
Benzinga
$100 Invested In Viking Therapeutics 5 Years Ago Would Be Worth This Much Today
April 15, 2024
Via
Benzinga
Viking Therapeutics's Options: A Look at What the Big Money is Thinking
April 09, 2024
Via
Benzinga
3 Biotech Stocks With Skyrocketing Potential: April 2024
April 24, 2024
These three biotech stocks, with robust fundamentals and long-term prospects represent the sector’s finest at this time.
Via
InvestorPlace
3 Red-Hot Biotech Rockets Blasting Off in 2024
April 24, 2024
The economy is looking very strong and the biotech industry even more so, thus consider these top three stocks for strong profits.
Via
InvestorPlace
Topics
Economy
Exposures
Economy
Missed Out on Novo Nordisk? 2 Healthcare Stocks With Big Catalysts on the Horizon.
April 24, 2024
Good news could be just around the corner for two drugmakers not named Novo Nordisk.
Via
The Motley Fool
Better Buy: Pfizer vs. Viking Therapeutics
April 23, 2024
These two pharma stocks have followed distinct paths of late. Which is the better investment?
Via
The Motley Fool
1 No-Brainer Vanguard Fund to Buy Right Now
April 23, 2024
This Vanguard growth fund is home to some of the world's most innovative companies.
Via
The Motley Fool
3 Stocks With the Potential to Surpass Analyst Expectations for 2024
April 23, 2024
These stocks to buy are set to surpass analyst expectations, with exciting product and service developments sparking unforeseen growth.
Via
InvestorPlace
Wegovy vs. Zepbound: Who Wins the Battle of the GLP-1 Drugs?
April 22, 2024
The GLP-1 weight loss trend continues to flourish, and the ante keeps rising; see how the winner between Wegovy and Zepbound can help your portfolio
Via
MarketBeat
These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?
April 16, 2024
These three biotech stocks are leading the sector higher on upbeat news but is this as good as it gets or do they have more gas in the tank?
Via
InvestorPlace
Viking Therapeutics: Strong Results In Obesity
April 13, 2024
With a potential best in class drug for oral and injectable use, Viking Therapeutics has to be on many Big Pharma/Bio acquisition wish lists, as the company represents a very scarce asset in the $100...
Via
Talk Markets
3 Magnificent Stocks That Could Double or More by 2030
April 13, 2024
There's no guarantee these stocks will double by 2030, but their growth prospects look great.
Via
The Motley Fool
Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027
April 12, 2024
For investors looking for a way to play weight-loss stocks in this current backdrop, here are three top options to consider right now.
Via
InvestorPlace
If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names
April 11, 2024
Capitalize on the biotech sector's boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments.
Via
InvestorPlace
Better Buy: CRISPR Therapeutics Vs. Viking Therapeutics
April 09, 2024
These rising drugmakers have serious arguments in their favor.
Via
The Motley Fool
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
19
20
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.